Respiratory Diseases
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Robert Clarke, Ph.D
Kinaset Therapeutics
PAO-02-022-CL-13Mar 12, 2022
Clinical Data
New Data Reinforces Benefits of Spiolto® Respimat® in Improving Patient Outcomes
Boehringer Ingelheim
PR-M10-19-NI-001Oct 01, 2019
Drug Development
Mylan and Theravance Will Receive FDA Decision on COPD Drug by November
Guy Tiene
Nice Insight
PAO-M02-18-NI-006Feb 06, 2018
Clinical Trials
COPD Patients Excited about AstraZeneca Trial Results
Guy Tiene
Nice Insight
PAO-M02-18-NI-002Feb 01, 2018